Transgenic mouse models of Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 908, Issue , 2000, Pages 260-266

  Bornemann, Klaus D ^a   Staufenbiel, Matthias ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; HEPARAN SULFATE; TAU PROTEIN;

ALZHEIMER DISEASE; ASTROCYTE; CONFERENCE PAPER; DISEASE MODEL; HIPPOCAMPUS; MICROGLIA; MOUSE; NEURITE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROPATHOLOGY; NONHUMAN; STEREOLOGY; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

MUS MUSCULUS;

EID: 0033943119     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06653.x     Document Type: Conference Paper

References (25)

1. 1. ANDRÄ, K. et al. 1996. Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol. Aging 17: 183-190.
2. 2. MULLAN, M. et al. 1992. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genet. 1: 345-347.
3. 3. STURCHLER-PIERRAT, C. et al. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94: 13287-13292.
4. 4. PAGANETTI, P. A. et al. 1996. Amyloid precursor protein truncated at any of the gamma-secretase sites is not cleaved to beta-amyloid. J. Neurosci. Res. 46: 283-293.
5. 5. STALDER, M. et al. 1999. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154: 1673-1684.
6. 6. PROBST, A. et al. 1991. Alzheimer's disease: a description of the structural lesions. Brain Pathol. 1: 229-239.
7. 7. STAUFENBIEL, M. & B. SOMMER. 1998. Transgenic animal models in the development of therapeutic strategies for Alzheimer's disease. In The Molecular Biology of Alzheimer's Disease. Genes and Mechanisms Involved in Amyloid Generation. C. Haass, Ed. : 309-326. Harwood Academic Publishers. Amsterdam, Netherlands.
8. 8. BORNEMANN, K.D. et al. Functional characteristics of activated microglia cells in APP23 transgenic mice. Submitted.
9. 9. CALHOUN, M.E. et al. 1998. Neuron loss in APP transgenic mice. Nature 395: 755-756.
10. 10. CALHOUN, M.E. et al. 1997. Impact of amyloid plaques on neuron number, synaptic bouton number, and cholinergic fiber length in a transgenic mouse model of Alzheimer's disease. Soc. Neurosci. Abstr. 23: 1637.
11. 11. WEST, M.J. et al. 1994. Differences in the pattern of hippocampal neuron loss in normal ageing and Alzheimer's disease. Lancet 344: 769-772.
12. 12. REGEUR, L. et al. 1994. No global neocortical nerve cell loss in brains from patients with senile dementia of Alzheimer's type. Neurobiol. Aging 15: 347-352.
13. 13. MATTSON, M.P. et al. 1993. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10: 243-254.
14. 14. BOWES, M.P. et al. 1994. Reduction of neuronal damage by a peptide segment of the amyloid/A4 protein precursor in a rabbit spinal cord ischemia model. Exp. Neurol. 129: 112-119.
15. 15. MUCKE, L. et al. 1994. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666: 151-167.
16. 16. ROCH, J.M. et al. 1994. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc. Natl. Acad. Sci. USA 91: 7450-7454.
17. 17. STAUFENBIEL, M. et al. 1997. Pathological features in APP transgenic mice resembling those of Alzheimer's disease. In Alzheimer's Disease II: Exploiting Mechanisms for Drug Development and Diagnosis. E. Friedman & L.M. Savage, Eds. : 4.2.1-4.2.12. IBC Library Series, International Business Communications. Southborough, MA, USA.
18. 18. TAGO, H. et al. 1987. Acetycholinesterase fibers and the development of senile plaques. Brain Res. 406: 363-369.
19. 19. GEULA, C. & M. MESULAM. 1989. Cholinesterases and the pathology of Alzheimer's disease. Neuroscience 33: 469-481.
20. 20. CALHOUN, M.E. et al. Amyloid plaque formation in APP transgenic mice is associated with synaptic bouton loss and alterations in the cholinergic system. Submitted.
21. 21. GALLYAS, F. 1971. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 19: 1-8.
22. 22. CARMEL, G. et al. 1996. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271: 32789-32795.
23. 23. POORKAJ, P. et al. 1998. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43: 815-826.
24. 24. HUTTON, M. et al. 1998. Coding and 5′ splice site mutations in tau associated with inherited dementia (FTDP-17). Nature 393: 702-705.
25. 25. SPILLANTINI, M.G. et al. 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95: 7737-7741.